Philmore O. Holman

765 total citations
12 papers, 638 citations indexed

About

Philmore O. Holman is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Philmore O. Holman has authored 12 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Oncology. Recurrent topics in Philmore O. Holman's work include T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Philmore O. Holman is often cited by papers focused on T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Philmore O. Holman collaborates with scholars based in United States, Italy and Hungary. Philmore O. Holman's co-authors include David M. Kranz, Sean M. O’Herrin, Eric V. Shusta, Phillip D. Holler, K. Dane Wittrup, Stephen C. Jameson, Guy Werlen, Nicholas R. J. Gascoigne, Mark A. Daniëls and Ed Palmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Immunity and The Journal of Immunology.

In The Last Decade

Philmore O. Holman

11 papers receiving 623 citations

Peers

Countries citing papers authored by Philmore O. Holman

Since Specialization

Citations

This map shows the geographic impact of Philmore O. Holman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philmore O. Holman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philmore O. Holman more than expected).

Fields of papers citing papers by Philmore O. Holman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philmore O. Holman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philmore O. Holman. The network helps show where Philmore O. Holman may publish in the future.

Co-authorship network of co-authors of Philmore O. Holman

This figure shows the co-authorship network connecting the top 25 collaborators of Philmore O. Holman. A scholar is included among the top collaborators of Philmore O. Holman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philmore O. Holman. Philmore O. Holman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Characterizing the Impact of CD8 Antibodies on Class I MHC Multimer Binding 2005 ·The Journal of Immunology ·Philmore O. Holman, Elizabeth R. Walsh, Stephen C. Jameson	14
2	The Central Tolerance Response to Male Antigen in Normal Mice Is Deletion and Not Receptor Editing 2003 ·The Journal of Immunology ·Philmore O. Holman, Elizabeth R. Walsh, Kristin A. Hogquist	7
3	The Impact of Duration versus Extent of TCR Occupancy on T Cell Activation 2001 ·Immunity ·Caridad Rosette, Guy Werlen, Mark A. Daniëls, Philmore O. Holman, S. Munir Alam, Paul Travers, Nicholas R. J. Gascoigne, Ed Palmer, Stephen C. Jameson	202
4	Development and applications of surface-linked single chain antibodies against T-cell antigens 2001 ·Journal of Immunological Methods ·Matthew D. Griffin, Philmore O. Holman, Qizhi Tang, (unknown), Ulf Korthäuer, David M. Kranz, Jeffrey A. Bluestone	25
5	Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152) 2000 ·The Journal of Immunology ·Matthew D. Griffin, David K. Hong, Philmore O. Holman, Kyung‐Mi Lee, Matthew J. Whitters, Sean M. O’Herrin, Francesca Fallarino, Mary Collins, David M. Segal, Thomas F. Gajewski, David M. Kranz, Jeffrey A. Bluestone	62
6	PROGRAMMED CELL DEATH SIGNALING VIA CELL-SURFACE EXPRESSION OF A SINGLE-CHAIN ANTIBODY TRANSGENE 2000 ·Transplantation ·Sanjay Kulkarni, Philmore O. Holman, (unknown), G A van Seventer, Jean Maguire van Seventer, (unknown), E. Steve Woodle	2
7	In vitroevolution of a T cell receptor with high affinity for peptide/MHC 2000 ·Proceedings of the National Academy of Sciences ·Phillip D. Holler, Philmore O. Holman, Eric V. Shusta, Sean M. O’Herrin, K. Dane Wittrup, David M. Kranz	239
8	Construction of a Single-Chain Antibody Derived From 5H7, A Monoclonal Antibody Specific for a Death Signaling Domain of Human Class I Major Histocompatibility Complex 1998 ·Transplantation Proceedings ·S. Kulkarni, Philmore O. Holman, David M. Kranz, Na Zhou, (unknown), E. Steve Woodle	0
9	Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells. 1996 ·PubMed ·Mukund Dole, Michael F. Clarke, Philmore O. Holman, Mary Benedict, Jean Lu, Rama Jasty, Peter Eipers, Curtis B. Thompson, Christina Rode, Carlos Bloch, (unknown), Valerie P. Castle	26
10	Characterization of transcripts from unrearranged V alpha 8 genes in the thymus. 1993 ·The Journal of Immunology ·Philmore O. Holman, Matthew E. Roth, Min Huang, David M. Kranz	8
11	Nonrandom use of J alpha gene segments. Influence of V alpha and J alpha gene location 1991 ·The Journal of Immunology ·Matthew E. Roth, Philmore O. Holman, David M. Kranz	48
12	Lewis acid catalysis of a Diels-Alder cycloaddition: An undergraduate organic experiment 1987 ·Journal of Chemical Education ·Alan P. Marchand, (unknown), (unknown), Philmore O. Holman	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact